|
EEF2K expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
4.41749999999796E-05 |
| Normal-vs-Stage3 |
2.52020626589911E-14 |
| Normal-vs-Stage4 |
2.71529999595899E-08 |
| Stage1-vs-Stage2 |
2.236800E-01 |
| Stage1-vs-Stage3 |
4.721200E-03 |
| Stage1-vs-Stage4 |
1.256860E-03 |
| Stage2-vs-Stage3 |
7.380200E-01 |
| Stage2-vs-Stage4 |
4.032800E-01 |
| Stage3-vs-Stage4 |
3.533800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.16469999703151E-08 |
| Normal-vs-Asian |
6.419900E-02 |
| Caucasian-vs-AfricanAmerican |
4.149400E-01 |
| Caucasian-vs-Asian |
1.784400E-01 |
| AfricanAmerican-vs-Asian |
2.091400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.583200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.738700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
7.782200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.762400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.887400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.688400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.590800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.943800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.789920E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.94749999999E-06 |
| Normal-vs-Grade 2 |
1.62458935193399E-12 |
| Normal-vs-Grade 3 |
9.99200722162641E-16 |
| Normal-vs-Grade 4 |
5.39790000031459E-07 |
| Grade 1-vs-Grade 2 |
1.125210E-01 |
| Grade 1-vs-Grade 3 |
2.363800E-03 |
| Grade 1-vs-Grade 4 |
4.108300E-02 |
| Grade 2-vs-Grade 3 |
2.157500E-03 |
| Grade 2-vs-Grade 4 |
8.723700E-02 |
| Grade 3-vs-Grade 4 |
8.267000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
5.72289993172603E-11 |
| ccA subtype-vs-ccB subtype |
7.645000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55431223447522E-15 |
| Normal-vs-N1 |
2.259100E-03 |
| N0-vs-N1 |
9.276800E-01 |
|
|
